KRMN vs RTX

KRMN exhibits a critical disconnect between its market price ($70.30) and its deterministic value, with a Piotroski F-Score of 2/9 indicating weak financial health. While the company shows explosive YoY earnings growth (482.9%), the valuation is unsustainable with a P/E ratio of 540.77 and a Graham Number of only $2.91. Heavy insider selling by the CEO and CFO, combined with a sharp recent technical decline, suggests that leadership views the current valuation as an exit opportunity. Despite bullish analyst price targets, the fundamental health and valuation metrics signal a high risk of a significant correction.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.